These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 26691948)
21. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Reid S; Schindler D; Hanenberg H; Barker K; Hanks S; Kalb R; Neveling K; Kelly P; Seal S; Freund M; Wurm M; Batish SD; Lach FP; Yetgin S; Neitzel H; Ariffin H; Tischkowitz M; Mathew CG; Auerbach AD; Rahman N Nat Genet; 2007 Feb; 39(2):162-4. PubMed ID: 17200671 [TBL] [Abstract][Full Text] [Related]
22. Homozygous loss of function BRCA1 variant causing a Fanconi-anemia-like phenotype, a clinical report and review of previous patients. Freire BL; Homma TK; Funari MFA; Lerario AM; Leal AM; Velloso EDRP; Malaquias AC; Jorge AAL Eur J Med Genet; 2018 Mar; 61(3):130-133. PubMed ID: 29133208 [TBL] [Abstract][Full Text] [Related]
23. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942 [TBL] [Abstract][Full Text] [Related]
24. Phenotypic variability in patients with Fanconi anemia and biallelic FANCF mutations. Tryon R; Zierhut H; MacMillan ML; Wagner JE Am J Med Genet A; 2017 Jan; 173(1):260-263. PubMed ID: 27714961 [TBL] [Abstract][Full Text] [Related]
25. Fanconi anemia and the development of leukemia. Alter BP Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269 [TBL] [Abstract][Full Text] [Related]
26. Fanconi anemia: current management. Kook H Hematology; 2005; 10 Suppl 1():108-10. PubMed ID: 16188650 [TBL] [Abstract][Full Text] [Related]
27. Screening Fanconi anemia lymphoid cell lines of non-A, C, D2, E, F, G subtypes for defects in BRCA2/FANCD1. Popp H; Kalb R; Fischer A; Lobitz S; Kokemohr I; Hanenberg H; Schindler D Cytogenet Genome Res; 2003; 103(1-2):54-7. PubMed ID: 15004464 [TBL] [Abstract][Full Text] [Related]
28. X-linked inheritance of Fanconi anemia complementation group B. Meetei AR; Levitus M; Xue Y; Medhurst AL; Zwaan M; Ling C; Rooimans MA; Bier P; Hoatlin M; Pals G; de Winter JP; Wang W; Joenje H Nat Genet; 2004 Nov; 36(11):1219-24. PubMed ID: 15502827 [TBL] [Abstract][Full Text] [Related]
29. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2. Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298 [TBL] [Abstract][Full Text] [Related]
30. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry. Rosenberg PS; Alter BP; Ebell W Haematologica; 2008 Apr; 93(4):511-7. PubMed ID: 18322251 [TBL] [Abstract][Full Text] [Related]
31. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Godthelp BC; Wiegant WW; Waisfisz Q; Medhurst AL; Arwert F; Joenje H; Zdzienicka MZ Mutat Res; 2006 Feb; 594(1-2):39-48. PubMed ID: 16154163 [TBL] [Abstract][Full Text] [Related]
32. Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) study. Levran O; Diotti R; Pujara K; Batish SD; Hanenberg H; Auerbach AD Hum Mutat; 2005 Feb; 25(2):142-9. PubMed ID: 15643609 [TBL] [Abstract][Full Text] [Related]
33. Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor. Dewire MD; Ellison DW; Patay Z; McKinnon PJ; Sanders RP; Gajjar A Pediatr Blood Cancer; 2009 Dec; 53(6):1140-2. PubMed ID: 19530235 [TBL] [Abstract][Full Text] [Related]
34. Validation of Fanconi anemia complementation Group A assignment using molecular analysis. Moghrabi NN; Johnson MA; Yoshitomi MJ; Zhu X; Al-Dhalimy MJ; Olson SB; Grompe M; Richards CS Genet Med; 2009 Mar; 11(3):183-92. PubMed ID: 19367192 [TBL] [Abstract][Full Text] [Related]
35. Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. Alter BP; Rosenberg PS; Brody LC J Med Genet; 2007 Jan; 44(1):1-9. PubMed ID: 16825431 [TBL] [Abstract][Full Text] [Related]
36. Fanconi anemia revisited: old ideas and new advances. dos Santos CC; Gavish H; Buchwald M Stem Cells; 1994 Mar; 12(2):142-53. PubMed ID: 8199559 [TBL] [Abstract][Full Text] [Related]
37. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study. Gillio AP; Verlander PC; Batish SD; Giampietro PF; Auerbach AD Blood; 1997 Jul; 90(1):105-10. PubMed ID: 9207444 [TBL] [Abstract][Full Text] [Related]
38. Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood. Maxwell KN; Patel V; Nead KT; Merrill S; Clark D; Jiang Q; Wubbenhorst B; D'Andrea K; Cohen RB; Domchek SM; Morrissette JJD; Greenberg RA; Babushok DV; Nathanson KL Clin Genet; 2023 Jan; 103(1):119-124. PubMed ID: 36089892 [TBL] [Abstract][Full Text] [Related]
39. Fanconi anemia and its diagnosis. Auerbach AD Mutat Res; 2009 Jul; 668(1-2):4-10. PubMed ID: 19622403 [TBL] [Abstract][Full Text] [Related]
40. Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Hirsch B; Shimamura A; Moreau L; Baldinger S; Hag-alshiekh M; Bostrom B; Sencer S; D'Andrea AD Blood; 2004 Apr; 103(7):2554-9. PubMed ID: 14670928 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]